Safety and Outcomes of Valproic Acid in Subarachnoid Hemorrhage Patients: A Retrospective Study
We did not observe an association between VPA and the rate of DCI. We found that VPA use was safe in SAH patients who have undergone endovascular treatment of their aneurysm.
Authors
- Joanna Chensi Yang (ORCID: https://orcid.org/0000-0001-9106-7080)
- Janice Weinberg (ORCID: https://orcid.org/0000-0002-3503-0061)
- Matthew J. Cobler-Lichter (ORCID: https://orcid.org/0000-0003-3848-1068)
- Kushak Suchdev (ORCID: https://orcid.org/0000-0002-0324-6589)
- David Y. Chung (ORCID: https://orcid.org/0000-0002-7149-5851)
- Anna M. Cervantes‐Arslanian (ORCID: https://orcid.org/0000-0002-6779-0647)
- Mohamad K. Abdalkader (ORCID: https://orcid.org/0000-0002-9528-301X)
- Ali Daneshmand (ORCID: https://orcid.org/0000-0001-7927-2030)
- Charlene Ong (ORCID: https://orcid.org/0000-0003-2377-3025)
- Thanh N. Nguyen (ORCID: https://orcid.org/0000-0002-2810-1685)
- David M. Greer (ORCID: https://orcid.org/0000-0002-2026-8333)
- Hormuzdiyar H. Dasenbrock (ORCID: https://orcid.org/0000-0002-2946-8286)
- Hayley Tatro (ORCID: https://orcid.org/0000-0001-7161-3611)
- Ava Cascone
Institutions
- Boston University (US)
- Boston Medical Center (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Clinical Neuropharmacology
- Published
- 2025-02-19
- DOI
- https://doi.org/10.1097/wnf.0000000000000627
- Primary Topic
- Intracranial Aneurysms: Treatment and Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00